Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs J Salonen, L Laitinen, AM Kaukonen, J Tuura, M Björkqvist, T Heikkilä, ... Journal of controlled release 108 (2-3), 362-374, 2005 | 642 | 2005 |
Mesoporous silicon in drug delivery applications J Salonen, AM Kaukonen, J Hirvonen, VP Lehto Journal of pharmaceutical sciences 97 (2), 632-653, 2008 | 558 | 2008 |
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ... ACS nano 4 (6), 3023-3032, 2010 | 366 | 2010 |
Mesoporous silica material TUD-1 as a drug delivery system T Heikkilä, J Salonen, J Tuura, MS Hamdy, G Mul, N Kumar, T Salmi, ... International journal of pharmaceutics 331 (1), 133-138, 2007 | 289 | 2007 |
Mesoporous systems for poorly soluble drugs W Xu, J Riikonen, VP Lehto International journal of pharmaceutics 453 (1), 181-197, 2013 | 262 | 2013 |
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery T Heikkilä, J Salonen, J Tuura, N Kumar, T Salmi, DY Murzin, MS Hamdy, ... Drug delivery 14 (6), 337-347, 2007 | 218 | 2007 |
Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles L Liu, X Bai, MV Martikainen, A Kårlund, M Roponen, W Xu, G Hu, ... Nature communications 12 (1), 5726, 2021 | 211 | 2021 |
Fabrication and chemical surface modification of mesoporous silicon for biomedical applications J Salonen, VP Lehto Chemical Engineering Journal 137 (1), 162-172, 2008 | 202 | 2008 |
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ... Acta biomaterialia 6 (7), 2721-2731, 2010 | 201 | 2010 |
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles LM Bimbo, E Mäkilä, T Laaksonen, VP Lehto, J Salonen, J Hirvonen, ... Biomaterials 32 (10), 2625-2633, 2011 | 186 | 2011 |
Semimetallic TiO2 Nanotubes R Hahn, F Schmidt‐Stein, J Salonen, S Thiemann, YY Song, J Kunze, ... Angewandte Chemie International Edition 48 (39), 7236-7239, 2009 | 186 | 2009 |
Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory− Huggins interaction parameter and phase diagram K Pajula, M Taskinen, VP Lehto, J Ketolainen, O Korhonen Molecular pharmaceutics 7 (3), 795-804, 2010 | 185 | 2010 |
Challenges and prospects of nanosized silicon anodes in lithium-ion batteries X Zhao, VP Lehto Nanotechnology 32 (4), 042002, 2020 | 183 | 2020 |
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ... Chemical research in toxicology 20 (12), 1913-1918, 2007 | 180 | 2007 |
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles D Liu, LM Bimbo, E Mäkilä, F Villanova, M Kaasalainen, ... Journal of Controlled Release 170 (2), 268-278, 2013 | 175 | 2013 |
Carbon doping of self-organized TiO2 nanotube layers by thermal acetylene treatment R Hahn, A Ghicov, J Salonen, VP Lehto, P Schmuki Nanotechnology 18 (10), 105604, 2007 | 154 | 2007 |
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles M Kilpeläinen, J Riikonen, MA Vlasova, A Huotari, VP Lehto, J Salonen, ... Journal of Controlled Release 137 (2), 166-170, 2009 | 149 | 2009 |
Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles T Limnell, J Riikonen, J Salonen, AM Kaukonen, L Laitinen, J Hirvonen, ... International journal of pharmaceutics 343 (1-2), 141-147, 2007 | 137 | 2007 |
The comparison of seven different methods to quantify the amorphous content of spray dried lactose VP Lehto, M Tenho, K Vähä-Heikkilä, P Harjunen, M Päällysaho, ... Powder Technology 167 (2), 85-93, 2006 | 135 | 2006 |
Multifunctional porous silicon for therapeutic drug delivery and imaging H A Santos, L M Bimbo, VP Lehto, A J Airaksinen, J Salonen, J Hirvonen Current drug discovery technologies 8 (3), 228-249, 2011 | 127 | 2011 |